Webinar: Design the optimal HCP Analysis strategy

20 February 2020

Did you know that a ‘good’ HCP analysis strategy should …
… be able to detect and document both broad-level HCPs and specific (critical) HCPs?

Coverage analysis of anti-HCP ELISA

In this 30 minute webinar Ejvind Mortz, COO, covers how to design a strategy for:

• Detecting and documenting HCP impurities in process samples and final drug
• Making a detailed comparison of ELISA kits to choose the ELISA assay with highest coverage of your product’s HCPs
• Avoiding specific critical HCPs based on detailed knowledge about their characteristics

Learn more about designing the optimal HCP strategy by signing up here >>